Early endoscopy improves survival in gastric cancer

Practitioner

Volumn 258, Issue 1773, 2014, Pages 23-27

  Hopper, Andrew D ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; CONFERENCE PAPER; DIGESTIVE TRACT ENDOSCOPY; EARLY DIAGNOSIS; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; RISK FACTOR; STOMACH TUMOR; SURVIVAL RATE;

AGED; EARLY DIAGNOSIS; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84906671905     PISSN: 00326518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (59)

1. Office for National Statistics. Cancer Registration Statistics England 2012. 19 June 2014. http://www.ons.gov.uk/ons/dcp171778-367563.pdf
2. Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev 1986;8: 1-27
3. Bertuccio P, Chatenoud L, Levi F et al. Recent patterns in gastric cancer: a global overview. Int J Cancer 2009;125: 666-73
4. de Martel C, Ferlay J, Franceschi S et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012;13: 607-15
5. Parkin DM. The global health burden of infectionassociated cancers in the year 2002. Int J Cancer 2006;118: 3030-44
6. Cavaleiro-Pinto M, Peleteiro B, Lunet N, Barros H. Helicobacter pylori infection and gastric cardia cancer: systematic review and meta-analysis. Cancer Causes Control 2011;22: 375-87
7. Fuccio L, Zagari RM, Eusebi LH et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med2009;151: 121-8
8. Fock KM, Talley N, Moayyedi P et al. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol 2008;23: 351-65
9. Hillier S, Fielder H. Screening for stomach cancer: A report for the National Screening Committee Nov 2008 www.screening.nhs.uk/policydb-download. php?doc=49
10. Roderick P, Davies R, Raftery J et al. Cost-effectiveness ofpopulation screening for Helicobacter pylori in preventing gastric cancer and peptic ulcer disease, using simulation. J Med Screen 2003; 10: 148-56
11. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum2004;83: 1-1438
12. Gonzalez CA, Pera G, Agudo A et al. Smoking and the risk of gastric cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). Int J Cancer 2003;107: 629-34
13. Ladeiras-Lopes R, Pereira AK, Nogueira A et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control 2008;19: 689-701
14. Tramacere I, Negri E, Pelucchi Cet al. A metaanalysis on alcohol drinking and gastric cancer risk. Ann Oncol 2012;23: 28-36
15. Duell EJ, Travier N, Lujan-Barroso L et al. Alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Am J Clin Nutr 2011;94: 1266-75
16. Shikata K, Kiyohara Y, Kubo M et al. A prospective study of dietary salt intake and gastric cancer incidence in a defined Japanese population: the Hisayama study. Int J Cancer 2006;119: 196-201
17. Fox JG, Dangler CA, Taylor NS et al. High-salt diet induces gastric epithelial hyperplasia and parietal cell loss, and enhances Helicobacter pylori colonization in C57BL/6 mice. Cancer Res 1999;59: 4823-8
18. Larsson SC, Bergkvist L, Wolk A. Fruit and vegetable consumption and incidence of gastric cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 2006;15: 1998-2001
19. Park B, Shin A, Park SK et al. Ecological study for refrigerator use, salt, vegetable, and fruit intakes, and gastric cancer. Cancer Causes Control 2011;22: 1497-502
20. Vannella L, Lahner E, Osborn J, Annibale B. Systematic review: gastric cancer incidence in pernicious anaemia. Aliment Pharmacol Ther 2013;37: 375-82
21. Hirota WK, Zuckerman MJ, Adler DG et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc 2006;63: 570-80
22. Dinis-Ribeiro M, Areia M, de Vries AC et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012; 44: 74-94
23. Fitzgerald RC, Hardwick R, Huntsman D et al. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet 2010;47: 436-44
24. Capelle LG, Van Grieken NC, Lingsma HF et al. Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands. Gastroenterology 2010;138: 487-92
25. Cairns SR, Scholefield JH, Steele RJ et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010;59: 666-89
26. National Institute for Health and Clinical Excellence. CG27. Referral guidelines for suspected cancer. NICE. London. 2005
27. Scottish Intercollegiate Guidelines Network. SIGN87. Management of oesophageal and gastric cancer. SIGN. Edinburgh. 2006
28. Allum WH, Blazeby JM, Griffin SM et al. Guidelines for the management of oesophageal and gastric cancer. Gut 2011;60: 1449-72
29. Meineche-Schmidt V, Jorgensen T. 'Alarm symptoms' in patients with dyspepsia: a three-year prospective study from general practice. Scand J Gastroenterol 2002;37: 999-1007
30. Kapoor N, Bassi A, Sturgess R, Bodger K. Predictive value of alarm features in a rapid access upper gastrointestinal cancer service. Gut 2005;54: 40-5
31. Bowrey DJ, Griffin SM, Wayman J et al. Use of alarm symptoms to select dyspeptics for endoscopy causes patients with curable esophagogastric cancer to be overlooked. Surg Endosc 2006;20: 1725-8
32. Panter SJ, O'Flanagan H, Bramble MG, Hungin AP. Empirical use of antisecretory drug therapy delays diagnosis of upper gastrointestinal adenocarcinoma but does not effect outcome. Aliment Pharmacol Ther 2004;19: 981-8
33. Madsen LG, Bytzer P. The value of alarm features in identifying organic causes of dyspepsia. Can J Gastroenterol 2000;14: 713-20
34. Hallissey MT, Allum WH, Jewkes AJ et al. Early detection of gastric cancer. BMJ 1990;301: 513-5
35. Christie J, Shepherd NA, Codling BW, Valori RM. Gastric cancer below the age of 55: implications for screening patients with uncomplicated dyspepsia. Gut 1997;41: 513-7
36. Gillen D, McColl KE. Does concern about missing malignancy justify endoscopy in uncomplicated dyspepsia in patients aged less than 55? Am J Gastroenterol 1999;94: 75-9
37. 37McColl KE, Murray LS, Gillen D et al. Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H pylori testing alone in the management of dyspepsia. BMJ2002;324: 999-1002
38. Lassen AT, Hallas J, Schaffalitzky de Muckadell OB. Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients: 6.7 year follow up of a randomised trial. Gut 2004;53: 1758-63
39. Jones R, Tait C, Sladen G, Weston-Baker J. A trial of a test-and-treat strategy for Helicobacter pylori positive dyspeptic patients in general practice. Int J Clin Pract 1999;53: 413-6
40. Yalamarthi S, Witherspoon P, McCole D, Auld CD. Missed diagnoses in patients with upper gastrointestinal cancers. Endoscopy 2004;36: 874-9
41. Bramble MG, Suvakovic Z, Hungin AP. Detection of upper gastrointestinal cancer in patients taking antisecretory therapy prior to gastroscopy. Gut 2000;46: 464-7
42. Wayman J, Hayes N, Griffin SM. The response of early gastric cancer to proton-pump inhibitors. N Engl J Med 1998;338: 1924-5
43. Dooley CP, Larson AW, Stace NH et al. Doublecontrast barium meal and upper gastrointestinal endoscopy. A comparative study. Ann Intern Med 1984;101: 538-45
44. Washington K. Seventh edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol 2010;17: 3077-9
45. Wang Z, Chen JQ. Imaging in assessing hepatic and peritoneal metastases of gastric cancer: a systematic review. BMC Gastroenterol 2011; 11: 19
46. de Graaf GW, Ayantunde AA, Parsons SL et al. The role of staging laparoscopy in oesophagogastric cancers. Eur J Surg Oncol 2007;33: 988-92
47. Gouzi JL, Huguier M, Fagniez PL et al. Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A French prospective controlled study. Ann Surg 1989;209: 162-6
48. Songun I, Putter H, Kranenbarg EM et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 2010;11: 439-49
49. Cheng Q, Pang TC, Hollands MJ et al. Systematic review and meta-analysis of laparoscopic versus open distal gastrectomy. J Gastrointest Surg 2014;18: 1087-99
50. National Oesophago-gastric Cancer Audit -2013, Annual report. 2013. www.hscic.gov.uk/catalogue/PUB11093/clin-audisupp-prog-oeso-gast-2013-rep.pdf
51. Cunningham D, Allum WH, Stenning SP et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355: 11-20
52. Cunningham D, Starling N, Rao S et al. Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med 2008;358: 36-46
53. Bang YJ, Van Cutsem E, Feyereislova A et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 2010;376: 687-97
54. Rivera F, Carrato A, Gravalos Cet al. Recommendations on current approach to gastric cancer. Clin Transl Oncol 2009;11: 518-25
55. Isenring EA, Capra S, Bauer JD. Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal or head and neck area. Br J Cancer 2004;91: 447-52
56. Douglas HR, Halliday D, Normand Cet al. Economic evaluation of specialist cancer and palliative nursing: Macmillan evaluation study findings. Int J Palliat Nurs 2003;9: 429-38
57. Verschuur EM, Steyerberg EW, Tilanus HW et al. Nurse-led follow-up of patients after oesophageal or gastric cardia cancer surgery: a randomised trial. Br J Cancer 2009;100: 70-6
58. Lepage C, Sant M, Verdecchia A et al. Operative mortality after gastric cancer resection and long-term survival differences across Europe.Br J Surg 2010;97: 235-9
59. De Angelis R, Sant M, Coleman MP et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-A population-based study. Lancet Oncol 2014;15(1): 23-34